JB Chemicals & Pharmaceuticals Limited Announces Departure of Chief Executive Officer
JB Chemicals & Pharmaceuticals Limited announced that Mr. Nikhil Chopra has ceased to be the Chief Executive Officer and Key Managerial Personnel of the company, effective March 31, 2026. This follows his earlier resignation as Whole-time Director, effective from the conclusion of the Board meeting held on January 21, 2026.Mr. Chopra’s resignation as CEO is attributed to personal reasons and to pursue other professional opportunities. He confirmed there are no other factors contributing to his departure.
The following table summarizes the details of Mr. Chopra’s cessation:
| Sr. No. | Disclosure requirement | |
|---|---|---|
| 1 | Reason for change | Resignation |
| 2 | Date of cessation | with effect from the closing of business hours of March 31, 2026. |
JB Chemicals & Pharmaceuticals Limited extends its gratitude to Mr. Chopra for his contributions during his tenure and wishes him success in his future endeavors.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.